How Has The Particle Therapy Market Size Evolved In Recent Years?
The particle therapy market has seen considerable growth due to a variety of factors.
•Over the past few years, there has been a substantial expansion in the particle therapy market. The market is expected to surge from $1.23 billion in 2024 to about $1.37 billion in 2025, maintaining a compound annual growth rate (CAGR) of 11.8%.
This growth during the historical period is ascribed to factors such as clinical research and studies, a rise in cancer cases, encouragement and financial support from government, collaborations within the industry, and advancements in treatment strategies.
What Is The Projected Growth Of The Particle Therapy Market?
The particle therapy market is expected to maintain its strong growth trajectory in upcoming years.
• In the upcoming years, the particle therapy market is predicted to witness a substantial expansion. It is set to grow to a staggering $2.19 billion by 2029, with a 12.4% compound annual growth rate (CAGR).
The surge in the forecast period is owing to factors such as increased healthcare spending, expanding applications beyond cancer treatment, a growth in the elderly population, evolution of healthcare infrastructure, and the incorporation of AI and data analytics. The forecast period is also likely to see significant trends like advancements in particle accelerator technology, refinement of hypofractionation techniques, combination therapies using proton and carbon ion, enhanced patient comfort, and the inception of biology-driven treatment methodologies.
What Are The Key Drivers Fueling Growth In The Particle Therapy Market?
The increased occurrence of cancer is anticipated to boost the expansion of the particle therapy market going forward. Cancer is a term that encompasses a diverse set of diseases marked by the abnormal rapid multiplication of cells within the body. Particle therapy's primary function is to treat cancer using precise and efficient radiation, where positively charged particles (protons) are accelerated to high velocities and then directed at the tumor. For example, the International Agency for Research on Cancer (IARC), an intergovernmental agency based in France, reported nearly 20 million new cancer cases in 2022, leading to almost 10 million fatalities resulting from the disease, as per data from April 2024. Forecasts based on demographic patterns suggest that by 2050, the annual rate of new cancer cases might reach 35 million, reflecting a 77% increase from the statistics in 2022. Therefore, the escalating prevalence of cancer is fuelling the expansion of the particle therapy market.
What Are The Principal Market Segments In The Global Particle Therapy Industry?
The particle therapy market covered in this report is segmented –
1) By Type: Proton Therapy, Heavy Ion Therapy
2) By System: Single-Room Systems, Multi-Room Systems
3) By Cancer Type: Pediatric Cancer, Prostate Cancer, Lung Cancer, Breast Cancer, Brain And Spinal Cord Cancer, Other Cancer Types
4) By End-User: Hospital, Academic And Research Centers
Subsegments:
1) By Proton Therapy: Pencil Beam Scanning Proton Therapy, Passive Scattering Proton Therapy, Intensity-Modulated Proton Therapy (IMPT)
2) By Heavy Ion Therapy: Carbon Ion Therapy, Helium Ion Therapy, Other Heavy Ions
Pre-Book The Particle Therapy Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Emerging Market Trends Are Altering The Particle Therapy Sector?
Elaborate particle therapy technologies are an emerging trend gaining traction in the particle therapy marketplace. Leading companies in this particular market are producing pioneering particle therapy technologies in order to remain competitive. For example, a major medical technology firm based in Sweden named RaySearch Laboratories launched its newest product in July 2023, referred to as the RayStation 2023B. This all-inclusive cancer treatment planning tool incorporates various leading-edge advancements in particle therapy such as offering support for individualized proton arcs and robust optimization based on Linear Energy Transfer (LET). The LET optimization lessens any potential adverse effects by limiting the LET exposure in risk organs while simultaneously targeting tumors with high LET particles to enhance tumor control. Additionally, the optimization of individualized proton arcs provides a larger range of beam angles resulting in more accurately shaped dose distributions and minimizes risk organ exposure. This innovative software also offers a streamlined process for standard pencil-beam scanning plans conversion and includes automatic planning for field-within-field photons, brachytherapy optimization based on specific points and an improved loading speed for data.
Who Are the Key Players in the Particle Therapy Market?
Major companies operating in the particle therapy market include:
• Hitachi Ltd.
• Mitsubishi Electric Corporation
• Siemens Healthineers AG
• Koninklijke Philips N.V
• GE Healthcare
• Sumitomo Heavy Industries Ltd.
• Varian Medical Systems Inc.
• Elekta AB
• Shinva Medical Instrument Co. Ltd.
• Toshiba Medical Systems Corporation
• Brainlab AG
• Accuray Incorporated
• IBA Worldwide
• Mevion Medical Systems Inc.
• Avante Health Solutions
• Provision Healthcare LLC
• ViewRay
• Panacea Biotec Ltd.
• PTW Freiburg GmbH.
• ProNova Solutions LLC
• Optivus Proton Therapy Inc.
• Xstrahl Inc.
• Protom International Inc.
• Danfysik AS
• SAH Global LLC
• Advanced Oncotherapy plc
• Particle Therapy Co-Operative Group
• Best Particle Therapy Inc.
What are the Regional Insights into the Particle Therapy Market?
North America was the largest region in the particle therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the particle therapy market report during the forecast period. The regions covered in the particle therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
